SCHEDULE 13D

Company

Esperion Therapeutics, Inc.

Filed

July 11, 2013

Accession Number

0000950005-13-000021

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →